MENU
+Compare
QNRX
Stock ticker: NASDAQ
AS OF
Aug 12 closing price
Price
$7.18
Change
+$0.14 (+1.99%)
Capitalization
4.22M

QNRX Quoin Pharmaceuticals Ltd Forecast, Technical & Fundamental Analysis

Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases... Show more

Industry: #Biotechnology
QNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for QNRX with price predictions
Aug 12, 2025

QNRX sees its Stochastic Oscillator ascends from oversold territory

On August 12, 2025, the Stochastic Oscillator for QNRX moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 58 instances where the indicator left the oversold zone. In of the 58 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where QNRX's RSI Oscillator exited the oversold zone, of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where QNRX advanced for three days, in of 210 cases, the price rose further within the following month. The odds of a continued upward trend are .

QNRX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 11, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on QNRX as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

QNRX moved below its 50-day moving average on July 22, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for QNRX crossed bearishly below the 50-day moving average on July 24, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QNRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for QNRX entered a downward trend on August 12, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.655) is normal, around the industry mean (18.823). P/E Ratio (0.007) is within average values for comparable stocks, (53.986). QNRX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.906). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (290.538).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. QNRX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QNRX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
QNRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a developer of biological products for cellular therapies

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
42127 Pleasant Forest Court
Phone
+1 703 980-4182
Employees
4
Web
https://www.quoinpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ATXG0.450.02
+4.83%
Addentax Group Corp
SMBC55.152.52
+4.79%
Southern Missouri Bancorp
INDB66.902.56
+3.98%
Independent Bank Corp
AVTX9.360.35
+3.94%
Avalo Therapeutics
DVA132.083.03
+2.35%
DaVita

QNRX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, QNRX has been loosely correlated with ATNM. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if QNRX jumps, then ATNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNRX
1D Price
Change %
QNRX100%
+1.92%
ATNM - QNRX
35%
Loosely correlated
+2.72%
WVE - QNRX
32%
Poorly correlated
+4.26%
ATNF - QNRX
32%
Poorly correlated
+206.59%
PRQR - QNRX
30%
Poorly correlated
+1.06%
ALGS - QNRX
28%
Poorly correlated
-1.78%
More